64835-48-9

Basic information

• Product Name: 4'-BROMO-3',5'-DIMETHYLACETANILIDE
• Synonyms: SALOR-INT L168122-1EA;4'-BROMO-3',5'-DIMETHYLACETANILIDE;N-(4-Bromo-3,5-dimethylphenyl)acetamide;N-Acetyl 4-bromo-3,5-dimethylaniline
• CAS NO: 64835-48-9
• Molecular Formula: C₁₀H₁₂BrNO
• Molecular Weight: 242.11
• Product Categories: Anilines, Amides & Amines;Bromine Compounds
• Mol File: 64835-48-9.mol
• Article Data: 8

Chemical Properties

• Melting Point: 180-181 °C(Solv: ethanol (64-17-5); water (7732-18-5))
• Boiling Point: 350.6°C at 760 mmHg
• Flash Point: 165.9°C
• Appearance: /
• Density: 1.413g/cm³
• Vapor Pressure: 4.33E-05mmHg at 25°C
• Refractive Index: 1.59
• Storage Temp.: Room temperature.
• PKA: 14.25±0.70(Predicted)
• CAS DataBase Reference: 4'-BROMO-3',5'-DIMETHYLACETANILIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-BROMO-3',5'-DIMETHYLACETANILIDE(64835-48-9)
• EPA Substance Registry System: 4'-BROMO-3',5'-DIMETHYLACETANILIDE(64835-48-9)

Safety Data

• Hazardous Substances Data: 64835-48-9(Hazardous Substances Data)

Usage

General Description

4'-Bromo-3',5'-dimethylacetanilide is an organic compound that belongs to the class of acetanilide derivatives. It is a substituted acetanilide with a bromine atom at the 4' position and methyl groups at the 3' and 5' positions of the aromatic ring. This chemical is commonly used in organic synthesis and pharmaceutical research as a building block for the preparation of various compounds. It has been studied for its potential biological activities and is of interest in the development of new drugs and pharmaceutical products. Additionally, it is used as a reagent in chemical reactions and as a precursor in the synthesis of other organic compounds.

InChI:InChI=1/C10H12BrNO/c1-6-4-9(12-8(3)13)5-7(2)10(6)11/h4-5H,1-3H3,(H,12,13)

Upstream product

• 108-69-0 3,5-dimethylaminoaniline 
• 2050-45-5 N-acetyl-3,5-dimethylaniline 
• 99-12-7 5-nitro-m-xylene 
• 59557-90-3 4-bromo-3,5-dimethylaniline 
• 108-24-7 acetic anhydride 
• 22364-28-9 N-(2-bromo-4,5-dimethylphenyl)acetamide 

Downstream Products

• 59557-90-3 4-bromo-3,5-dimethylaniline 
• 1021165-59-2 N-(4-formyl-3,5-dimethyl-phenyl)-acetamide 
• 1021162-15-1 2-(4-acetylamino-2,6-dimethyl-phenyl)-3H-benzoimidazole-5-carboxylic acid (3,4-dimethyl-phenyl)-amide 
• 1253917-10-0 (E)-N-(4-(2-((2-cyclohexyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-en-8-yl)sulfonyl)vinyl)-3,5-dimethylphenyl)acetamide 
• 312304-54-4 1-bromo-4-iodo-2,6-bis[(dimethylamino)methyl]benzene 
• 689260-53-5 2-bromo-5-iodo-1,3-dimethylbenzene 

Relevant articles and documents

8,9-DIHYDROIMIDAZOLE[1,2-A]PYRIMIDO[5,4-E]PYRIMIDINE-5(6H)-KETONE COMPOUND

Disclosed are 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-one compounds, specifically represented by the Formula I: or a pharmaceutically acceptable salt or prodrug thereof, wherein A and R1-R7 are defined herein. Compounds having Formula I are Wee1 kinase inhibitors. Therefore, compounds of the disclosure may be used to treat diseases caused by abnormal Wee1 activity.

SPIROIMIDAZOLONE DERIVATIVE

The present invention relates to a compound represented by the following formula (1): wherein W, X, Y, R1, R2, R33, R34, m and n are as defined in the claims, or a pharmacologically acceptable salt thereof.

Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders

Aryl sulfonamide and sulfonyl compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.